Laboratoire 7 MED

What Laboratoire 7 MED does

Laboratoire 7 MED is a privately held French medical device manufacturer founded in 1997 and headquartered in Loriol sur Drôme (309 Allée des Lavandes, ZA Champgrand, 26270). The company designs, manufactures, and markets Class III medical devices with CE marking, specializing in hormone-free female contraception. Its core technology centers on copper-based intrauterine devices (DIUs/IUDs, also known in French as "stérilets") that provide contraception without hormones, paired with specialized insertion and removal kits (KITs de pose et de retrait) intended for use by trained healthcare professionals. The company has extended its portfolio to include a blood-based pregnancy self-test (Test de Grossesse Sanguin) positioned as delivering laboratory-grade early detection results.

The company's commercial model is sales-led and channel-supported. It reaches gynecologists, midwives (sages-femmes), and general practitioners through a dedicated professional portal (Espace professionnels de santé) that provides product access and training resources. A separate distributor channel supports wholesale distribution domestically, and the corporate website features an explicit distributor recruitment page ("Are you a distributor?"). Customer segments span medical specialists, midwives, primary care physicians, women as end consumers, and medical device distributors. Since 2016, the company has operated ACADÉMIE 7MED, a professional training program in France that delivers theoretical and practical instruction on IUD placement, delivered at congresses and in clinical settings.

Revenue mechanics are anchored in hardware sales of medical devices (DIUs, kits, and pregnancy tests) sold to healthcare professionals and distributors under a quote-based, pay-as-you-go pricing model with no publicly disclosed price list. The company also offers professional training services through ACADÉMIE 7MED. Laboratoire 7 MED operates exclusively in France, describes itself as the national reference (LA référence) for hormone-free female contraception, and is privately held with no disclosed external investment, parent company, or acquisition history. The firm has 11-50 employees and continues to release product updates, including a new generation of placement and removal kits in 2025.

Name

Laboratoire 7 MED

Legal name

Laboratoire 7 MED

Website

https://7med-diu.fr

Company type

Private

Founded year

1997

Operating status

Operating

Headcount range

11–50 employees

Short description

Laboratoire 7 MED is a privately held French Class III medical device manufacturer, founded in 1997, specializing in hormone-free copper intrauterine devices, professional insertion/removal kits, and blood-based pregnancy tests for gynecologists, midwives, and GPs in France.

Ownership category

akta.pro rank

Product category

Women's Health Medical Devices

NAICS

Surgical and Medical Instrument Manufacturing (339112), In-Vitro Diagnostic Substance Manufacturing (325413), Medical Equipment and Supplies Manufacturing (3391)

SIC

Surgical & Medical Instruments & Apparatus (3841), In Vitro & In Vivo Diagnostic Substances (2835)

akta.pro primary industry

Pregnancy, Fertility & Women’s Health Rapid Tests (hCG, ovulation, vaginal infection) (HLAHAOAF)

akta.pro secondary industry

Family Planning & Contraception (Including Abortion Care) (HLAKAJAG)

Keywords

• Copper intrauterine devices
• Hormone-free contraception
• Gynecological medical devices
• Pregnancy testing products
• Professional healthcare training

Headquarters

HQ city

Hauterive

HQ country

France

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Medical Device Sales - DIU and KITs: Sale of copper intrauterine devices (DIU/IUD) and associated insertion/removal kits to healthcare professionals and distributors.
2. Blood Pregnancy Test: Sale of blood-based pregnancy tests to healthcare professionals and potentially directly to consumers.
3. Professional Training Services: Training services provided to healthcare professionals through ACADÉMIE 7MED for proper device placement techniques.

Pricing tiers

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Core offering

Laboratoire 7 MED designs, manufactures, and markets class III medical devices (CE-marked) focused on hormone-free female contraception, primarily copper intrauterine devices (DIUs/IUDs) and associated insertion/removal kits. The company also sells a blood-based pregnancy self-test providing laboratory-quality results, and supports its products with the ACADÉMIE 7MED professional training program launched in 2016.

Product overview

Laboratoire 7 MED is a French medical device manufacturer specializing in hormone-free female health products. Founded in 1997, the company operates as a single-brand portfolio offering three interconnected product lines: copper intrauterine devices (DIUs/IUDs) paired with professional insertion and removal kits, and a blood-based pregnancy test. The products are distributed exclusively to healthcare professionals (gynecologists, midwives, general practitioners) through a dedicated professional portal, with complementary training provided via the ACADÉMIE 7MED program launched in 2016.

Differentiator

Problem solved

Functional benefit

Brands

• ACADÉMIE 7MED: Training and education platform for healthcare professionals (gynecologists, midwives, general practitioners) on DIU placement and medical device usage, established in 2016.

Products and services

• 7MED DIUs et KITs

Quantifiable outcome

• Blood pregnancy test provides laboratory-quality reliable results

Segments5 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature2 records

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• HRA Pharma (Perrigo): Women's health specialty company known for emergency contraception and reproductive health products. Comparable as a focused reproductive-health device/specialty pharma player with similar clinician go-to-market.
• SMB Corporation: Indian-headquartered manufacturer of intrauterine devices and other contraceptive devices with global distribution. Comparable as a copper IUD manufacturer serving similar clinician customers in similar price-sensitive contexts.
• Mona Lisa NV: European manufacturer of copper IUDs and other women's health devices. Comparable as a similarly-sized, niche-focused copper IUD specialist operating in European markets.
• CooperSurgical (CooperCompanies): Manufacturer of Paragard, the leading copper IUD in the US. Most direct peer given identical core product (non-hormonal copper IUD) and overlapping clinician customer base.
• Pregna International: Manufacturer of IUDs and other long-acting reversible contraceptives (LARCs). Directly comparable product portfolio targeting similar clinician customers globally.

Broad incumbents

• Organon & Co. Global women's health company with a broad portfolio in contraception, fertility, and reproductive health. Comparable end-customer base (gynecologists, women) but operates at significantly larger scale across many categories.
• Church & Dwight (First Response): Owner of First Response, the leading US pregnancy test brand. Comparable on the pregnancy test product line via a consumer-OTC model, though not present in copper IUDs.
• Gedeon Richter: European pharmaceutical company with a meaningful women's health and contraceptive device franchise. Comparable as a European-headquartered player targeting gynecologists and reproductive-health prescribers.
• SPD Swiss Precision Diagnostics (Clearblue): Global leader in home pregnancy and ovulation testing, including blood-based pregnancy diagnostics. Directly comparable on the 7MED pregnancy test product line though with a much broader portfolio and consumer-led brand.
• Bayer (Women's Health / Mirena): Global pharma leader with the Mirena hormonal IUD franchise and broader contraceptive portfolio. Competes indirectly with 7MED in the same clinician-prescribed contraceptive device category but across a much wider product set.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/laboratoire-7-med

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Laboratoire 7 MED